Pulmonary pathologic findings of fatal 2009 Pandemic influenza A/H1N1 viral infections

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 2, 2010, Pages 235-243

  Gill, James R ^a   Sheng, Zong Mei ^b   Ely, Susan F ^a   Guinee Jr , Donald G ^d,e   Beasley, Mary B ^f   Suh, James ^g   Deshpande, Charuhas ^h   Mollura, Daniel J ^c   Morens, David M ^j   Bray, Mike ^c   Travis, William D ⁱ   Taubenberger, Jeffery K ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Laboratory of Clinical Infectious Diseases   (United States)

^c Integrated Research Facility   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e VIRGINIA MASON MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CHILD; COMORBIDITY; EPIDEMIC; FEMALE; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; TIME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; TIME FACTORS;

EID: 76149106017     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2): 179-186. (Pubitemid 36068705)
2. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med. 2009;361(3):225-229.
3. Taubenberger JK, Morens DM. Pandemic influenza - including a risk assessment of H5N1. Rev Sci Tech. 2009;28(1):187-202.
4. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002;76(1):105-115.
5. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15-22.
6. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197-201.
7. Chan M. World now at the start of 2009 influenza pandemic. World Health Organization. http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html. Accessed June 15, 2009.
8. Pandemic (H1N1) 2009 - update 64. World Health Organization. http:// www.who.int/csr/don/en/index.html. Accessed November 17, 2009.
9. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53-60.
10. Centers for Disease Control and Prevention. 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep. 2009;58(33):913-918.
11. Kelly HA, Grant KA, Williams S, Fielding J, Smith D. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust. 2009;191(3):146-149.
12. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill. 2009; 14(34):1-6.
13. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009; 14(33):1-6.
14. Centers for Disease Control and Prevention. H1N1 flu (swine flu): resources for laboratories. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/h1n1flu/lab/. Accessed June 2, 2009.
15. Krafft AE, Duncan BW, Bijwaard KE, Taubenberger JK, Lichy JH. Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: the Armed Forces Institute of Pathology experience and literature review. Mol Diagn. 1997;2(3):217-230.
16. Krafft AE, Russell KL, Hawksworth AW, et al. Evaluation of PCR testing of ethanol-fixed nasal swab specimens as an augmented surveillance strategy for influenza virus and adenovirus identification. J Clin Microbiol. 2005;43(4):1768-1775.
17. Runstadler JA, Happ GM, Slemons RD, et al. Using RRT-PCR analysis and virus isolation to determine the prevalence of avian influenza virus infections in ducks at Minto Flats State Game Refuge, Alaska, during August 2005. Arch Virol. 2007;152(10):1901-1910.
18. Wang R, Sheng ZM, Taubenberger JK. Detection of novel (swine origin) H1N1 influenza A virus by quantitative real-time RT-PCR. J Clin Microbiol. 2009; 47(8):2675-2677.
19. Qi L, Kash JC, Dugan VG, et al. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol. 2009;83(8):3754-3761.
20. LeCount ER. Disseminated necrosis of the pulmonary capillaries in influenzal pneumonia. JAMA. 1919;72(21):1519-1520.
21. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1-4.
22. Guarner J, Packard MM, Nolte KB, et al. Usefulness of immunohistochemical diagnosis of streptococcus pneumoniae in formalin-fixed, paraffinembedded specimens compared with culture and gram stain techniques. Am J Clin Pathol. 2007;127(4):612-618.
23. Mulder J, Hers JFP. Influenza. Groningen, the Netherlands: Wolters- Noordhoff Publishing; 1972:287.
24. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962-970.
25. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499-522.
26. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med. 2002;346(8):591-602.
27. Guarner J, Paddock CD, Shieh WJ, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis. 2006;43(2):132-140.
28. Guarner J, Shieh WJ, Dawson J, et al. Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol. 2000;114(2):227-233.
29. Ahmed R, Oldstone MB, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol. 2007;8(11):1188-1193.
30. Kuiken T, Taubenberger JK. The pathology of human influenza revisited. Vaccine. 2008;26(suppl 4):D59-D66.
31. McCullers JA. Planning for an influenza pandemic: thinking beyond the virus. J Infect Dis. 2008;198(7):945-947.
32. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine. 2009;27(suppl 3):C9-C14.
33. Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006; 443(7111):578-581.
34. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203-1207.
35. Centers for Disease Control and Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749-752.
36. Haque AK, Gadre S, Taylor J, Haque SA, Freeman D, Duarte A. Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects. Arch Pathol Lab Med. 2008;132(9):1397-1404.
37. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(19):521-524.